- Report
- December 2025
- 343 Pages
Global
From €4213EUR$4,799USD£3,645GBP
- Report
- October 2025
- 204 Pages
Global
From €4213EUR$4,799USD£3,645GBP
- Report
- December 2025
- 250 Pages
Global
From €4213EUR$4,799USD£3,645GBP
- Report
- November 2025
- 120 Pages
Global
From €1598EUR$1,820USD£1,382GBP
€2458EUR$2,800USD£2,127GBP
- Report
- October 2025
- 140 Pages
Global
From €1598EUR$1,820USD£1,382GBP
€2458EUR$2,800USD£2,127GBP
- Report
- March 2025
- 1000 Pages
Global
From €2225EUR$2,535USD£1,925GBP
€3424EUR$3,900USD£2,962GBP
- Report
- January 2026
- 270 Pages
Global
From €1598EUR$1,820USD£1,382GBP
€2458EUR$2,800USD£2,127GBP
- Report
- November 2025
- 120 Pages
Global
From €1883EUR$2,145USD£1,629GBP
€2897EUR$3,300USD£2,506GBP
- Report
- October 2025
- 100 Pages
Global
From €1712EUR$1,950USD£1,481GBP
€2634EUR$3,000USD£2,279GBP
- Report
- August 2025
- 100 Pages
Global
From €1883EUR$2,145USD£1,629GBP
€2897EUR$3,300USD£2,506GBP
- Report
- June 2025
- 210 Pages
Global
From €1712EUR$1,950USD£1,481GBP
€2634EUR$3,000USD£2,279GBP
- Report
- March 2025
- 150 Pages
Global
From €1712EUR$1,950USD£1,481GBP
€2634EUR$3,000USD£2,279GBP
- Report
- December 2025
- 166 Pages
Global
From €4082EUR$4,650USD£3,532GBP
- Report
- April 2025
- 388 Pages
Global
From €4082EUR$4,650USD£3,532GBP
- Report
- April 2025
- 203 Pages
Global
From €4082EUR$4,650USD£3,532GBP
- Report
- March 2025
- 160 Pages
Global
From €4082EUR$4,650USD£3,532GBP
- Report
- March 2025
- 211 Pages
Global
From €4082EUR$4,650USD£3,532GBP
- Report
- November 2025
- 139 Pages
Global
From €4082EUR$4,650USD£3,532GBP
- Report
- April 2025
- 150 Pages
Global
From €5223EUR$5,950USD£4,519GBP
- Report
- April 2025
- 140 Pages
Global
From €4302EUR$4,900USD£3,722GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more